Study links ceramide levels to prostate cancer drug response differences
Ceramides-lipid molecules in cells that affect many physiological functions including cell differentiation, migration, and death-and their metabolites have…
Precision Radiation Therapy Could Offer New Hope For Hard-To-Treat Cancers
There is a growing number of approvals for radionuclide therapy, a class of cancer medicines which deliver radioactive…
Metformin boosts an exercise-linked metabolite and may help control weight in prostate cancer patients
A clinical study suggests metformin may reproduce part of exercise’s metabolic signature in prostate cancer patients, raising Lac-Phe…
Metformin mimics exercise-related metabolic effects in prostate cancer patients
A new study has found that metformin, a widely prescribed diabetes drug, may mimic one of exercise’s core…
PSMA therapy may postpone hormone treatment in prostate cancer patients
Where previous research showed that PSMA therapy for prostate cancer can prolong the lives of patients who have…
Estradiol patches as effective as injections for locally advanced prostate cancer
Hormone patches are as good at controlling locally advanced prostate cancer as the injections typically used to deliver…
Detailed cell atlas reveals earliest changes in prostate cancer
Prostate cancer affects one in five Australian men, making it the most common cancer in the country. Now,…
Microplastics May Be Messing With Your Prostate, Too
4 min read A small study found microplastics in 90 percent of cancerous prostate tumors. Some of the…
New AI tool aims to ease prostate cancer diagnostic workload
Increasing use of blood tests to detect prostate cancer is leading to overworked doctors. NTNU has now created…
Living With Prostate Cancer: The Hidden Burden On Family Caregivers
KUALA LUMPUR, March 12 — For families whose loved one is living with prostate cancer, the journey is…
International urology conference showcases advancements in prostate cancer diagnostics
Nearly 300 abstracts on prostate cancer research from around the world will be presented at the European Association…
Low baseline testosterone predicts aggressive prostate cancer progression risk
A new study led by researchers at The University of Texas MD Anderson Cancer Center found that prostate cancer patients with low testosterone levels may have a higher risk of cancer progressing to a more aggressive form while under active surveillance. …